- Review
- Open access
- Published:
Enhancing HIV/STI decision-making: challenges and opportunities in leveraging predictive models for individuals, healthcare providers, and policymakers
Journal of Translational Medicine volume 22, Article number: 886 (2024)
Abstract
The prevention and control of human immunodeficiency virus and sexually transmitted infections (HIV/STI) face challenges worldwide, especially in China. Prediction tools, which analyze medical data and information to make future predictions, were once mainly used in HIV/STI research to help make diagnostic or prognostic decisions, has have now extended to the public as a freely accessible tool. This article provides an overview of the different roles of prediction tools in preventing and controlling HIV/STI from the perspectives of individuals, healthcare providers, and policymakers. For individuals, prediction tools serve as a risk assessment solution that assess their risk and consciously improve risk reception or change risky behaviors. For researchers, prediction tools are powerful for assisting in identifying risk factors and predicting patients’ infection risk, which can inform timely and accurate intervention planning in the future. In order to achieve the best performance, current research increasingly underscores the necessity of considering multiple levels of information, such as socio-behavioral data, in developing a robust prediction tool. In addition, it is also crucial to conduct trials in clinical settings to validate the effectiveness of prediction tools. Many studies only use theoretical parameters such as model accuracy to estimate its predictive. If these improvements are made, the application of prediction tools could be a potentially inspiring solution in the prevention and control of HIV/STI, and an opportunity for achieving the World Health Organization’s agenda to end the HIV/STI epidemic by 2030.
Introduction
The strategies of prevention and control of human immunodeficiency virus and sexually transmitted infections (HIV/STI) in China need to be improved. From 2010 to 2019, there was a rise in the prevalence of chlamydia, syphilis, gonorrhea, HIV, and AIDS, yet there is a possibility of significant underdiagnosis and underreporting [1]. Chlamydia infection is the most prevalent STI in China [2]. However, it has not been incorporated as a reportable STI in the national STI surveillance program. It is only addressed in 105 STI surveillance sites, and merely 23.4% of these sites offer nucleic acid amplification tests [3]. In 2021, Gonorrhea was reported as the fourth most common infectious disease in China [4], and its testing rate was also shown to be insufficient [3]. Even HIV testing among key populations is underestimated. Two studies revealed that 25.8% of people who use drugs (PWUD) [5] and 32.6% of female sex workers (FSW) [6] has received HIV testing in the past year. Additionally, a national study reported that just 25% of healthcare providers (HPs) offer HIV testing upon patient request [7].
The significant underestimation of HIV/STI underscores the importance of early detection and treatment as essential components of HIV/STI control strategies [8]. In an effort to promote early detection and treatment, prediction tools have been developed to help HPs in identify at-risk groups, and deliver targeted and timely interventions [9,10,11,12]. In addition, these tools can support public health system by serving as a prognostic and epidemiological tools to monitor variations in prevalence and risk factors across different regions [13,14,15], and to access the adherence to the intervention [16, 17] and its outcomes [18]. This comprehension can aid in the development of tailed prevention, control, and resource allocation strategies for diverse regions [19]. The users of prediction tools have gradually shifted from being used only by HPs to being available to the public. The use of such easily accessible prediction tools can enable individuals to assess their risk of reinfection/infection of HIV/STI and recognize the importance of testing and behavior change [20,21,22,23].
The purpose of this study is to review the current published HIV/STI prediction tools, and explore their specific roles in assisting individuals, enhancing clinical settings and informing public health strategies. Additionally, this review aims to summarize the limitations in the current research and propose new directions for future HIV/STIs prediction studies.
Prediction tools for patients
Studies have indicated that a lack of awareness about the risks of HIV/STI and the fear of stigma when seeking healthcare service are significant obstacles for individuals to undergo testing in China [7, 24, 25]. It was pointed out that improving individuals’ awareness of HIV will increase the uptake of HIV testing and promote safety behavior [26]. For instance, a survey indicated that after acquiring HIV-related knowledge, 75.2% of patients were motivated to seek healthcare services [27]. Given the current challenges, implementing self-assessment tools could serve as a practical approach to motivate individuals.
Recently, studies have led to the development of HIV/STI risk prediction tools that aid individuals in estimating their current or future risk of HIV/STI infection [12, 20,21,22,23, 28]. In 2020, an online HIV risk prediction tool, named SexPro, was developed by Scott et al. [22] with high predictive efficiency. This tool is cater to American men who have sex with men (MSM), especially Black MSM. After the questions related to sexual history have been answered, an HIV risk score of 1–20 will be generated and displayed. More broadly, Xu et al. [21] developed an online tool, MySTIRisk, which is open to the public and based on several machine learning (ML) algorithms to predict the concurrent risk of HIV, syphilis, gonorrhea, and chlamydia within 1 year. Upon completion of a 13-question questionnaire, a report will be generated detailing the risk of acquiring HIV/STI, as well as providing recommendations for risk reduction and testing. Prior to the implementation of such prediction tools in clinical practice, it is essential to conduct clinical validation studies to confirm the effectiveness of these risk prediction tools in behavior changing. Yun et al. [20] conducted a randomized controlled trial (RCT) to reveal the preliminary effects of their online HIV risk prediction tool [23] in reducing the risk of HIV infection and promoting HIV testing among Chinese MSM. The results of the study indicated that the prediction tool had a positive impact on sexual behavior, with higher rates of condom use and fewer male sexual partners among those who used the tool in 3 months compared to those who did not. These findings indicated the potential effectiveness of the prediction tool in promoting safer sexual practices. Further research and validation studies are needed to confirm these results and assess the long-term impact of using such prediction tools. The evidences from other studies supported the idea that internet-based interventions can be effective in helping individuals overcome stigma related to privacy and portability [29]. And these interventions have been shown to improve risk perceptions [30], which can lead to positive changes in behavior. The potential of prediction tools for self-risk assessment and behavior changing is substantial, and it is important to emphasize the need for clinical validation studies to evaluate the effectiveness of these tools when applied in clinical settings.
Prediction tools for healthcare providers
There are limited healthcare professionals in China who have trained in HIV/STI knowledge and skills to offer appropriated testing and intervention to every patient [7, 24]. Additionally, studies have demonstrated that inadequate testing and high costs are barriers to early detection and treatment, leading to the increased spread of HIV/STI in China [3].
Studies have been conducted in the area of developing prediction tools to prioritize essential groups. Findings from Xia et al. show that using ML algorithms, people living with HIV (PLWH) at high viral loads can be identified, which is the key component of HIV prevention programs to control the transmission [11]. Notably, the authors claimed that when this tool is used in clinical practice, the HPs does not require HIV sequence data to identify PLWH, which is of great benefit in resource-limited settings. It is crucial to inform and ensure that patients undergo regular testing, as recommended by guidelines. Xu et al. developed a ML model to identify individuals who timely attend clinics and undergo HIV/STI testing after receiving reminders. By examining a person’s triage reasons, sexual history, and previous reminder methods and frequency, HPs were able to assess the patient’s willingness to undergo testing and take immediate action [16]. These models have the potential to be used in routine care, even in resource-limited settings, to efficiently prioritize essential groups. Once more, the clinical effectiveness of using these models requires evaluation.
Prediction tools for policymakers
Predicting epidemic trends
In China, rural-to-urban migrants are often considered a high-risk group for HIV/STI infection and transmission [31]. Improved economic prospects entice rural residents to relocate to urban centers, with approximately 385 million migrants [1] typically commuting between urban and rural areas during Chinese major holidays. Due to China’s strict household registration system, rural migrants do not have access to all the social and health welfare available in cities [32]. This leads to poor living condition, unstable income, limited access to healthcare services, and inadequate social support. All these contribute to increased vulnerability to HIV/STI in China [31, 32]. A systematic review and meta-analysis found that the risk of HIV infection among migrants was 6.7 times higher than that of the general population. Among female migrants, the risk was even higher, at 12.18 times [33].
The cyclical occurrence of AIDS, gonorrhea and syphilis in China is associated with the migration from rural to urban areas [14]. Zhu et al. [14] utilized time series analysis of the monthly incidence of AIDS, gonorrhea and syphilis over the past decade to forecast the occurrence of these diseases over the next year and five years in China. Their findings suggested that the incidence of HIV/STIs declined significantly to its lowest during the Chinese New Year, but subsequently rose rapidly to a relatively high level after the holiday period. Similarly, Weng et al. [15] developed a time-series prediction model to predict the incidence of chlamydia in Shenzhen, a developed city with large number of migrants in China. The authors also observed that the occurrence of chlamydia varied during the same season. Both of these studies have confirmed the findings of previous studies: a large number of migrants back home and limited health services due to holidays or major events will lead to changes in the incidence of HIV/STI. Ultimately, time-series models can be used to predict the HIV/STI incidence and can serve as a tool for policymakers to rationally allocate health resources and draft HIV/STI prevention and control plans in a timely manner.
Predicting the effectiveness of government policies
Regulations and policies play a crucial role as structural interventions that can either support or hinder efforts in controlling and preventing HIV/STI. FSWs, who are disproportionately affected by HIV/STI infections, are hesitant to undergo testing due to the illegality of commercial sex, resulting in limited access to HIV prevention services in China [34]. Conversely, the implementation of a free antiretroviral therapy (ART) policy in China resulted in a 0.69% decrease in HIV infection per 100 person-years [31].
Time series prediction models can be utilized to assess the impact of laws and policies on HIV/STI. Ruiz et al. [19] utilized time-series analysis to predict HIV infection in the absence of Syringe exchange program (SEP) and compared it with the actual HIV infection in the presence of SEP. The findings indicate that HIV diagnosis would rise with the implementation of SEP. Consistently, SEP has been demonstrated to be linked to a reduction in bloodborne HIV/AIDS infections among PWUD [35]. As a structural intervention, the risky environment of PWUD is improved to promote their health rather than changing their behavior and social interaction. Likewise, Zhao and colleagues [36] developed a time-series prediction model to predict the anticipated HIV/AIDS cases from 2020 to 2022, excluding the impact of Coronavirus disease. The results showed that an additional 1,314 HIV/AIDS cases would occur every month. Moreover, the lower number of HIV/AIDS cases is hypothesized to be attributed to underdiagnosis, underreporting, and social isolation. The authors emphasized that while lockdown policies help maintain social distancing, they also create distance from healthcare resources, including ART treatment and testing, which could result in a rapid increase in incidence in the future. According to the prediction tool, it is recommended that resource allocation for HIV/AIDS should be prioritized to enable ongoing testing and surveillance during future pandemics.
Discussion
This review underscores the impact of prediction tools in the prevention and control of HIV/STI, ultimately resulting in improved outcomes for individuals, clinic settings, and public health. Awareness of the potential to use existing information to predict HIV/STIs outcomes is growing rapidly. Recently, the China Center for Disease Control and Prevention (CDC) released guideline for online intervention in HIV, encouraging the development of internet-based HIV risk-assessment tools to identify the risk of HIV infection in the general or specific populations [37]. The crucial importance of utilizing easily accessible, person-centered predictive tools is emphasized.
Research on the effectiveness of predictive models in clinical practice is scarce. Most of the studies evaluated the performance of the model by AUC or accuracy, but these indicators cannot be used to evaluate whether the model is clinically feasible. Of the aforementioned studies, only Yun et al. [23] conducted a RCT to validate the clinical efficacy of the model, which confirmed previous hypothesis that the predictive model could help MSM in improve high-risk behavior. TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement was published in 2015 to help improve the quality of the prediction model research and ensure the reliability and reproducibility of model results [38]. Of the studies mentioned earlier, only Xia et al. [11] developed their model following the TRIPOD guidelines. However, there is a concern that the argument may be overinterpreted. The authors claim that the model is not limit to PLWH with specific characteristics, but also applies to women and heterosexual men with high-risk characteristics, such as high viral load. However, performance for individuals with a high viral load is only 0.56 which means the model has limited ability to discriminate such population. However, this also highlights that following the TRIPOD guidelines can make the findings of such interdisciplinary research more accessible to the audience. Nevertheless, the performance of prediction tools should be interpreted with caution in the absence of clinical validations, otherwise the effectiveness of the model in the clinical settings would be difficult to validate.
The generalizability of prediction tools remains limited. First, some tools are only designed for specific populations, such as MSM [16, 22, 23] and PLWH [17, 18]. MSM are disproportionately affected by HIV/STIs, whom is at higher risk of acquiring HIV/STIs than are heterosexual men and women [39, 40]. However, in 2021, 22% of new HIV infections still occurred among people who reported heterosexual contact in US, while this proportion in China was about 70% [35, 41]. Second, certain tools are designed specifically to predict only HIV [11, 12, 17, 18, 22, 23, 28] or STIs [10, 13, 15] outcomes. It is well established that STIs facilitate HIV transmission by disrupting protective mucosal barriers and recruiting susceptible immune cells to the site of infection [42], and the high prevalence of STIs co-infection among PLWH will impede efforts to prevent HIV transmission using HIV treatment alone [43]. A systematic review revealed that 16.3% of PLWH reported having a STI infection, and co-infection with a STI increases HIV viral shedding and infectiousness [43]. Therefore, focusing solely on awareness and intervention for HIV infection may overlook the risk of STIs. Future studies should incorporate diverse datasets to develop models that can be used in various settings, thereby enhancing the robustness of the model.
The performance of prediction tools varies due to insufficient data. An Australia study sought to develop a ML-based tool to predict chlamydia retesting and reinfection rate over the next 12 months [10]. However, the performance was poor for both outcomes, leading the authors to recommend that future research should not only rely solely on electronic health record (EHR), but should also encompass macro-level data, such as behavioral and social factors [10]. In the aforementioned study, the accuracy of predicting clinic attendance was lacking, promoting the authors to recommend the inclusion of psychological and social characteristics in modeling, as these factors are related to behavior [16]. Controlling and preventing the spread and infection of HIV/STIs involves more than just offering free ART or condoms. Researchers are increasingly acknowledging that the social and structural factors contributing to HIV/STI infection, such as power dynamics within relationships, access to services and transportation, and economic inequalities, also contribute to people being at risk [44]. The US CDC recommends integrating social and behavioral determinants of health into EHR to enhance health outcomes [45], and other reviews have similarly advised that future HIV/STI intervention should consider the relevant factors at various levels, ranging from individual to the structural considerations [31, 44, 46]. In Pakistan, a research took into account behavioral and structural factors including drug use and urbanization, and integrated them with EHR to develop an HIV prediction model that achieved an accuracy of 82% [28]. Similarly, Saldana et al. [12] also integrated socio-demographic factors and Social Vulnerability Index to predict HIV incidence, with good performance for both men and women.
Subsequent clinical validation studies are essential for future research, as they are crucial for maintaining the credibility of prediction tools. In addition, aside from EHR, the inclusion of socio-behavioral information such as Social Vulnerability Index [47], Social Support Rating Scale [48], Sexual Relationship Power Scale [49], etc., should be considered. When socio-behavioral information is lacking, natural language processing (NLP) can be utilized to extract relevant data from EHR, particularly as information such as sexual history is often documented in narrative form within clinical notes. Research has shown that NPL-based EHR can improve the predictive performance in HIV risk assessment [50]. Overall, through the implementation of clinical validation studies and the integration of socio-behavioral information, the value of prediction tools can be significantly enhanced, bringing us closer to achieving the World Health Organization (WHO) 2030 goal of ending AIDS and STI epidemic by 2030 [51].
Conclusions
Predictive models hold the potential to extract valuable insights from extensive data to aid HIV/STI decision making for individuals, clinical settings, and public health. Emphasizing the inclusion of social and behavior determinants is crucial for developing more precise and applicable models. However, the inadequacy of clinical validation studies has hindered their potential for clinical practice, thereby limiting their effectiveness in reaching the WHO 2030 goal even further.
Data availability
Not applicable.
References
National Bureau of Statistics of China. China Statistical Yearbook 2022; 2022.
Yue X, Gong X, Li J, Zhang J, Gu H. Epidemiology of genital chlamydial infection in China in 2019. Int J Dermatology Venereol. 2020;3:86–90. https://doi.org/10.1097/jd9.0000000000000099.
Zhang JH, Yue XL, Li J, Gong XD. [Investigation of detection capacities of laboratories in sexually transmitted disease surveillance areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:1509–13. https://doi.org/10.3760/cma.j.cn112338-20191115-00812.
Chinese Center for Disease Control and Prevention. The 2021 National Overview of Statutory Infectious Disease Epidemics; 2021.
Jiang Z, Xiu C, Yang J, Zhang X, Liu M, Chen X, Liu D. HIV test uptake and related factors amongst heterosexual drug users in Shandong province, China. PLoS ONE. 2018;13:e0204489. https://doi.org/10.1371/journal.pone.0204489.
Zhao PZ, Wang YJ, Cheng HH, Zhang Y, Tang WM, Yang F, Zhang W, Zhou JY, Wang C. Uptake and correlates of chlamydia and gonorrhea testing among female sex workers in Southern China: a cross-sectional study. BMC Public Health. 2021;21:1477. https://doi.org/10.1186/s12889-021-11526-w.
Ong JJ, Peng MH, Wong WW, Lo Y-R, Kidd MR, Roland M, Zhu SZ, Jiang SF. Opportunities and barriers for providing HIV testing through community health centers in mainland China: a nationwide cross-sectional survey. BMC Infect Dis. 2019;19:1054. https://doi.org/10.1186/s12879-019-4673-0.
Chinese Center for Disease Control and Prevention. Implementation Plan for Containing the Spread of HIV/AIDS (2019–2022); 2019.
Zhan M, Tong Z, Chen S, Miao Y, Yang Y. Establishing a prediction model for recurrence of condyloma acuminatum. Eur J Med Res. 2022;27:183. https://doi.org/10.1186/s40001-022-00816-7.
Xu X, Chow EPF, Fairley CK, Chen M, Aguirre I, Goller J, Hocking J, Carvalho N, Zhang L, Ong JJ. Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic. Front Public Health. 2023;10. https://doi.org/10.3389/fpubh.2022.1031372.
Xia Q, Wertheim JO, Braunstein SL, Misra K, Udeagu CC, Torian LV. Use of molecular HIV surveillance data and predictive modeling to prioritize persons for transmission-reduction interventions. Aids. 2020;34:459–67. https://doi.org/10.1097/qad.0000000000002452.
Saldana CS, Burkhardt E, Pennisi A, Oliver K, Olmstead J, Holland DP, Gettings J, Mauck D, Austin D, Wortley P, et al. Development of a machine learning modeling Tool for Predicting Human Immunodeficiency Virus Incidence Using Public Health Data from a County in the Southern United States. Clin Infect Dis. 2024. https://doi.org/10.1093/cid/ciae100.
Kebede Kassaw A-A, Melese Yilma T, Sebastian Y, Yeneneh Birhanu A, Sharew Melaku M, Surur Jemal S. Spatial distribution and machine learning prediction of sexually transmitted infections and associated factors among sexually active men and women in Ethiopia, evidence from EDHS 2016. BMC Infect Dis. 2023;23. https://doi.org/10.1186/s12879-023-07987-6.
Zhu Z, Zhu X, Zhan Y, Gu L, Chen L, Li X. Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011–2021. Front Public Health. 2022;10:966813. https://doi.org/10.3389/fpubh.2022.966813.
Weng RX, Fu HL, Zhang CL, Ye JB, Hong FC, Chen XS, Cai YM. Time series analysis and forecasting of chlamydia trachomatis incidence using surveillance data from 2008 to 2019 in Shenzhen, China. Epidemiol Infect. 2020;148:e76. https://doi.org/10.1017/s0950268820000680.
Xu X, Fairley CK, Chow EPF, Lee D, Aung ET, Zhang L, Ong JJ. Using machine learning approaches to predict timely clinic attendance and the uptake of HIV/STI testing post clinic reminder messages. Sci Rep. 2022;12:8757. https://doi.org/10.1038/s41598-022-12033-7.
Chen H, Long R, Hu T, Chen Y, Wang R, Liu Y, Liu S, Xu C, Yu X, Chang R, et al. A model to predict adherence to antiretroviral therapy among people living with HIV. Sex Transm Infect. 2022;98:438–44. https://doi.org/10.1136/sextrans-2021-055222.
Jiang F, Xu Y, Liu L, Wang K, Wang L, Fu G, Wang L, Li Z, Xu J, Xing H, et al. Construction and validation of a prognostic nomogram for predicting the survival of HIV/AIDS adults who received antiretroviral therapy: a cohort between 2003 and 2019 in Nanjing. BMC Public Health. 2022;22. https://doi.org/10.1186/s12889-021-12249-8.
Ruiz MS, OʼRourke A, Allen ST, Holtgrave DR, Metzger D, Benitez J, Brady KA, Chaulk CP, Wen LS. Using interrupted Time Series Analysis to measure the impact of Legalized Syringe Exchange on HIV diagnoses in Baltimore and Philadelphia. J Acquir Immune Defic Syndr. 2019;82(Suppl 2):S148–54. https://doi.org/10.1097/qai.0000000000002176.
Yun K, Chu Z, Zhang J, Geng W, Jiang Y, Dong W, Shang H, Xu J. Mobile phone intervention based on an HIV Risk Prediction Tool for HIV Prevention among men who have sex with men in China: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021;9:e19511. https://doi.org/10.2196/19511.
Xu X, Ge Z, Chow EPF, Yu Z, Lee D, Wu J, Ong JJ, Fairley CK, Zhang LA. Machine-learning-based risk-prediction Tool for HIV and Sexually Transmitted Infections Acquisition over the Next 12 months. J Clin Med. 2022;11:1818.
Scott H, Vittinghoff E, Irvin R, Liu A, Nelson L, Del Rio C, Magnus M, Mannheimer S, Fields S, Van Tieu H, et al. Development and validation of the personalized sexual Health Promotion (SexPro) HIV Risk Prediction Model for men who have sex with men in the United States. AIDS Behav. 2020;24:274–83. https://doi.org/10.1007/s10461-019-02616-3.
Yun K, Xu J, Leuba S, Zhu Y, Zhang J, Chu Z, Geng W, Jiang Y, Shang H. Development and validation of a personalized social media platform-based HIV Incidence Risk Assessment Tool for men who have sex with men in China. J Med Internet Res. 2019;21:e13475. https://doi.org/10.2196/13475.
Ong JJ, Peng M, Zhu S, Lo YJ, Fairley CK, Kidd MR, Roland M, Jiang S, Wong WCW. Opportunities and barriers to STI testing in community health centres in China: a nationwide survey. Sex Transm Infect. 2017;93:566–71. https://doi.org/10.1136/sextrans-2017-053196.
Operario D, Wang D, Zaller ND, Yang M-F, Blaney K, Cheng J, Hong Q, Zhang H, Chai J, Szekeres G, et al. Effect of a knowledge-based and skills-based programme for physicians on risk of sexually transmitted reinfections among high-risk patients in China: a cluster randomised trial. Lancet Global Health. 2016;4:e29–36. https://doi.org/10.1016/S2214-109X(15)00249-1.
Tso LS, Tang W, Li H, Yan HY, Tucker JD. Social media interventions to prevent HIV: a review of interventions and methodological considerations. Curr Opin Psychol. 2016;9:6–10. https://doi.org/10.1016/j.copsyc.2015.09.019.
Zhou L, Guo J, Fan L, Tian J, Zhou B. Survey of motivation for use of voluntary counseling and testing services for HIV in a high risk area of Shenyang, China. BMC Health Serv Res. 2009;9:23. https://doi.org/10.1186/1472-6963-9-23.
Nisa SU, Mahmood A, Ujager FS, Malik M. HIV/AIDS predictive model using random forest based on socio-demographical, biological and behavioral data. Egypt Inf J. 2023;24:107–15. https://doi.org/10.1016/j.eij.2022.12.005.
Clement ME, Lovett A, Caldwell S, Beckford J, Hilgart M, Corneli A, Flickinger T, Dillingham R, Ingersoll K. Development of an mHealth app to support the Prevention of sexually transmitted infections among Black men who have sex with men engaged in pre-exposure Prophylaxis Care in New Orleans, Louisiana: qualitative user-centered design study. JMIR Form Res. 2023;7:e43019. https://doi.org/10.2196/43019.
Tran BX, Bui TM, Do AL, Boyer L, Auquier P, Nguyen LH, Nguyen AHT, Ngo TV, Latkin CA, Zhang MWB, et al. Efficacy of a Mobile Phone-Based Intervention on Health Behaviors and HIV/AIDS Treatment Management: Randomized Controlled Trial. J Med Internet Res. 2023;25:e43432. https://doi.org/10.2196/43432.
Zhao Y, Luo T, Tucker JD, Wong WC. Risk factors of HIV and other sexually transmitted infections in China: a systematic review of reviews. PLoS ONE. 2015;10:e0140426. https://doi.org/10.1371/journal.pone.0140426.
Wang B, Li X, Stanton B, Fang X. The influence of social stigma and discriminatory experience on psychological distress and quality of life among rural-to-urban migrants in China. Soc Sci Med. 2010;71:84–92. https://doi.org/10.1016/j.socscimed.2010.03.021.
Zhang L, Chow EP, Jahn HJ, Kraemer A, Wilson DP. High HIV prevalence and risk of infection among rural-to-urban migrants in various migration stages in China: a systematic review and meta-analysis. Sex Transm Dis. 2013;40:136–47. https://doi.org/10.1097/OLQ.0b013e318281134f.
Qiao S, Li X, Zhang C, Zhou Y, Shen Z, Tang Z, Stanton B. Psychological fears among low-paid female sex workers in southwest China and their implications for HIV prevention. PLoS ONE. 2014;9:e111012. https://doi.org/10.1371/journal.pone.0111012.
US Center for Disease Control and Prevention. HIV Surveillance Supplemental Report: Estimated HIV Incidence and Prevalence in the United States, 2017–2021; 2023.
Zhao T, Liu H, Bulloch G, Jiang Z, Cao Z, Wu Z. The influence of the COVID-19 pandemic on identifying HIV/AIDS cases in China: an interrupted time series study. Lancet Reg Health West Pac. 2023;36:100755. https://doi.org/10.1016/j.lanwpc.2023.100755.
National Center for AIDS/STD Control and Prevention. C.C. Trial guideline for Internet + HIV/AIDS intervention; 2021.
Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13:1. https://doi.org/10.1186/s12916-014-0241-z.
Ye Z-H, Chen S, Liu F, Cui S-T, Liu Z-Z, Jiang Y-J, Hu Q-H. Patterns of sexually transmitted co-infections and Associated factors among men who have sex with men: a cross-sectional study in Shenyang, China. Front Public Health. 2022;10. https://doi.org/10.3389/fpubh.2022.842644.
Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27:238–43. https://doi.org/10.1016/j.annepidem.2017.02.003.
National Center for AIDS/STD Control and Prevention. C.C. Updated on the core information for HIV prevention in 2020; 2020.
Ward H, Rönn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:305–10. https://doi.org/10.1097/COH.0b013e32833a8844.
Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87:183–90. https://doi.org/10.1136/sti.2010.047514.
Kaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr. 2014;66(Suppl 3):S250–258. https://doi.org/10.1097/qai.0000000000000236.
US Centers for Disease Control and Prevention. Social Determinants Health (SDOH); 2024.
Chen M, Tan X, Padman R. Social determinants of health in electronic health records and their impact on analysis and risk prediction: a systematic review. J Am Med Inf Assoc. 2020;27:1764–73. https://doi.org/10.1093/jamia/ocaa143.
Center for Disease Control and Preventin/ Agency for Toxic Substances and Disease Registry/, Geospatial Reeserach A, Program S. CDC/ATSDR Social Vulnerability Index 2022 database. 2022.
Cauce AM, Felner RD, Primavera J. Social Support in High Risk adolescents: Structural Components and adaptive impact. Am J Community Psychol. 1982;10:417–28. https://doi.org/10.1007/BF00893980.
Pulerwitz J, Gortmaker SL, DeJong W. Measuring sexual Relationship Power in HIV/STD Research. Sex Roles. 2000;42:637–60. https://doi.org/10.1023/A:1007051506972.
Feller DJ, Zucker J, Yin MT, Gordon P, Elhadad N. Using Clinical notes and Natural Language Processing for Automated HIV Risk Assessment. J Acquir Immune Defic Syndr. 2018;77:160–6. https://doi.org/10.1097/qai.0000000000001580.
World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva; 2022.
Acknowledgements
Not applicable.
Funding
This research received no specific funding.
Author information
Authors and Affiliations
Contributions
YC and YW contributed to the conception and design of the review. The first draft of the manuscript was written by YC and LC. FG and BL contributed to the final review and editing of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Chen, Y., Yu, W., Cai, L. et al. Enhancing HIV/STI decision-making: challenges and opportunities in leveraging predictive models for individuals, healthcare providers, and policymakers. J Transl Med 22, 886 (2024). https://doi.org/10.1186/s12967-024-05684-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12967-024-05684-9